Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance

Expert Review of Molecular Diagnostics

Volumn 11, Issue 7, 2011, Pages 691-694

  Cho, William C S ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

cancer biomarker; colorectal cancer; CRC; feces; methylation; microRNA; miRNA; noninvasive colorectal cancer screening

Indexed keywords

MICRORNA;

ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; EPIGENETICS; FECES ANALYSIS; GENE SILENCING; HUMAN; PROGNOSIS; RNA METHYLATION;

EID: 80052783071     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.57     Document Type: Article

References (22)

1. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J. Clin. 58(3), 130-160 (2008). (Pubitemid 351830299)
2. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 128(1), 192-206 (2005). (Pubitemid 40039970)
3. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12(2), 99-110 (2011).
4. Cho WC. MicroRNAs in cancer - from research to therapy. Biochim. Biophys. Acta 1805(2), 209-217 (2010).
5. Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 42(8), 1273-1281 (2010).
6. Balaguer F, Link A, Lozano JJ et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res. 70(16), 6609-6618 (2010).
7. Luo X, Burwinkel B, Tao S, Brenner H. MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol. Biomarkers Prev. 20(7), 1272-1286 (2011).
8. Kalimutho M, Di Cecilla S, Del Vecchio Blanco G et al. Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. Br. J. Cancer 104(11), 1770-1778 (2011).
9. He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature 435(7043), 828-833 (2005). (Pubitemid 40839734)
10. Toyota M, Suzuki H, Sasaki Y et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68(11), 4123-4132 (2008).
11. Lujambio A, Calin GA, Villanueva A et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA 105(36), 13556-13561 (2008).
12. Schetter AJ, Leung SY, Sohn JJ et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299(4), 425-436 (2008). (Pubitemid 351185951)
13. Glöckner SC, Dhir M, Yi JM et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 69(11), 4691-4699 (2009).
14. Chang E, Park DI, Kim YJ et al. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepatogastroenterology 57(10), 720-727 (2010).
15. Kamimae S, Yamamoto E, Yamano HO et al. Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors. Cancer Prev. Res. 4(5), 674-683 (2011).
16. Suzuki H, Yamamoto E, Nojima M et al. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 31(12), 2066-2073 (2010).
17. Kubo T, Toyooka S, Tsukuda K et al. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin. Cancer Res. 17(15), 4965-4974 (2011).
18. Wang Z, Chen Z, Gao Y et al. DNA hypermethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer. Cancer Biol. Ther. 11(5), 490-496 (2011).
19. Cho WC. Recent progress in genetic variants associated with cancer and their implications in diagnostics development. Expert Rev. Mol. Diagn. 10(6), 699-703 (2010).
20. Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med. 3(5), 31 (2011).
21. Chen X, Zhang J, Zen K, Zhang CY. MicroRNAs as blood-based biomarkers of cancer. In: MicroRNAs in Cancer Translational Research. Cho WC (Ed.).Springer, NY, USA, 499-532 (2011).
22. Cho WC. Circulating microRNAs as minimally invasive biomarkers for cancer theragnosis and prognosis. Front. Genet. 2(7), 1-6 (2011).